These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 22682513

  • 1. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN.
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical importance of transforming growth factor-beta but not of tumor necrosis factor-alpha gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype.
    Balog A, Borbényi Z, Gyulai Z, Molnár L, Mándi Y.
    Pathobiology; 2005 Oct; 72(3):165-70. PubMed ID: 15860935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.
    Park JY, Park MH, Park H, Ha J, Kim SJ, Ahn C.
    Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338
    [Abstract] [Full Text] [Related]

  • 9. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC, do Carmo RF, Moura P, Silva JL, Vasconcelos LR, Cavalcanti MS, Muniz MT, Aroucha ML, Siqueira ER, Cahú GG, Pereira LM, Coêlho MR.
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [Abstract] [Full Text] [Related]

  • 10. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E.
    Cytokine; 2004 Jul 07; 27(1):7-14. PubMed ID: 15207246
    [Abstract] [Full Text] [Related]

  • 11. [Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients].
    Li Z, Li HQ, Yan Y, Liu Y, Hao W, Niu JQ, Yin JM, Li H.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 14; 87(30):2105-8. PubMed ID: 17988528
    [Abstract] [Full Text] [Related]

  • 12. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
    Zhang L, Wu G, Herrle F, Niedergethmann M, Keese M.
    Cancer Genomics Proteomics; 2012 Aug 14; 9(5):287-95. PubMed ID: 22990108
    [Abstract] [Full Text] [Related]

  • 13. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK, Shaker OG, Ismail MF, Sayed NH.
    Gene; 2013 Sep 25; 527(2):516-20. PubMed ID: 23845776
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.
    Talaat RM, Esmail AA, Elwakil R, Gurgis AA, Nasr MI.
    Chin J Cancer; 2012 Jan 25; 31(1):29-35. PubMed ID: 22200181
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
    Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ.
    Genes Immun; 2000 Aug 25; 1(6):386-90. PubMed ID: 11196686
    [Abstract] [Full Text] [Related]

  • 16. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer.
    Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Avellini C, Minisini R, Pirisi M.
    Cytokine; 2008 Nov 25; 44(2):256-61. PubMed ID: 18809335
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M.
    Hepatology; 2003 Jan 25; 37(1):65-71. PubMed ID: 12500190
    [Abstract] [Full Text] [Related]

  • 18. Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients.
    Bouzgarrou N, Hassen E, Gabbouj S, Schvoerer E, Ben Mami N, Triki H, Chouchane L.
    Gastroenterol Clin Biol; 2010 Jan 25; 34(4-5):297-304. PubMed ID: 20537485
    [Abstract] [Full Text] [Related]

  • 19. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.
    Cancer Epidemiol Biomarkers Prev; 2011 Jul 25; 20(7):1439-46. PubMed ID: 21610221
    [Abstract] [Full Text] [Related]

  • 20. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N.
    J Viral Hepat; 2007 Dec 25; 14(12):841-8. PubMed ID: 18070287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.